Topic: market exclusivity
Pfizer knew things would take a turn after generics for its blockbuster Lyrica launched stateside in July. But did it know it would be this bad?
Indivior cut its 2019 sales projections nearly in half after a $3 billion indictment accused the company of illegally marketing Suboxone Film.
Amid a national conversation over drug prices, Democrats are raising concern with the trade deal negotiated between the U.S., Canada and Mexico.
The FDA tacked three extra years of generic-free sales onto Eagle Pharma's Treanda after a court-granted sister drug Bendeka orphan drug exclusivity.
Eli Lilly’s $500 million-plus ADHD med Strattera succumbed to generics Tuesday as four drugmakers won FDA green lights for their copycat.
Being among the world’s largest generic drug players certainly comes with its challenges. With 57,000 full-time employees around the globe, Israel’s Teva Pharmaceutical Industries came in at No. 3 among the world’s top generic drugmakers, raking in $8.8 billion with its copycats last year.
Marathon’s Emflaza pricing remains in an unwelcome spotlight as eight more senators zero in on the company and its newly approved, $89,000 DMD med.